High Grade Gliomas: Clinical Trials

3 trials for High Grade Gliomas, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Recruiting 2, Completed 1

Follow High Grade Gliomas: new trials by email Literature Review of High Grade Gliomas trials Research Report on High Grade Gliomas

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Nivolumab, Nivolumab-IRDye800 - Brain Cancer, HGG
Early Phase 1RecruitingEben Rosenthal382026-03-272026-07-01
A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
SGT-53, hypofractionated radiotherapy with immunotherapy, Nivolumab - CNS Malignancies, Medulloblastoma Recurrent
Early Phase 1RecruitingChildren's National Research Institute182025-12-162026-04-29
Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5
F-18 RGD-K5 - Sarcoma, Melanoma
Early Phase 1CompletedSiemens Molecular Imaging162008-08-012009-02-02

Narrower conditions

Astrocytoma (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Laryngeal Diseases (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Oligodendroglioma (1)  ·  Pinealoma (1)  ·  Sarcoma (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neoplasms, Neuroepithelial (3)  ·  Neuroectodermal Tumors (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Breast Diseases (1)  ·  Central Nervous System Neoplasms (1)

Interventions

Nivolumab (2)  ·  Immunotherapy (1)

Sponsors

Children's National Research Institute (1)  ·  Eben Rosenthal (1)  ·  Siemens Molecular Imaging (1)

Countries

United States (3)

Top investigators

Michael Yu, MD (1)  ·  Patrick Kelly, MD (1)

Results publications

PMID 22499613